Bontempelli M - Search Results

1

Perioperative Minimal Induction Therapy: A Further Step toward More Effective Immunosuppression in Transplantation.

Gennarini A, Cravedi P, Marasà M, Perna A, Rota G, Bontempelli M, Sandrini S, Remuzzi G, Ruggenenti P. Gennarini A, et al. Among authors: bontempelli m. J Transplant. 2012;2012:426042. doi: 10.1155/2012/426042. Epub 2012 May 20. J Transplant. 2012. PMID: 22685630 Free PMC article.

2

Rituximab for idiopathic membranous nephropathy: who can benefit?

Ruggenenti P, Chiurchiu C, Abbate M, Perna A, Cravedi P, Bontempelli M, Remuzzi G. Ruggenenti P, et al. Among authors: bontempelli m. Clin J Am Soc Nephrol. 2006 Jul;1(4):738-48. doi: 10.2215/CJN.01080905. Epub 2006 Jun 14. Clin J Am Soc Nephrol. 2006. PMID: 17699281

3

CTLA4Ig alone or in combination with low-dose cyclosporine fails to reverse acute rejection of renal allograft in the rat.

Perico N, Amuchastegui S, Bontempelli M, Remuzzi G. Perico N, et al. Among authors: bontempelli m. Transplantation. 1996 May 15;61(9):1320-2. doi: 10.1097/00007890-199605150-00006. Transplantation. 1996. PMID: 8629290 No abstract available.

4

Preliminary results of intrathymic injection of donor cells to prevent acute rejection in human heart transplantation.

Remuzzi G, Ferrazzi P, Bontempelli M, Senni M, Glauber M, Ruggenenti P, Perico N. Remuzzi G, et al. Among authors: bontempelli m. J Am Soc Nephrol. 1995 Oct;6(4):1291-4. doi: 10.1681/ASN.V641291. J Am Soc Nephrol. 1995. PMID: 8589299 Clinical Trial.

5

Toward novel antirejection strategies: in vivo immunosuppressive properties of CTLA4Ig.

Perico N, Imberti O, Bontempelli M, Remuzzi G. Perico N, et al. Among authors: bontempelli m. Kidney Int. 1995 Jan;47(1):241-6. doi: 10.1038/ki.1995.30. Kidney Int. 1995. PMID: 7731152 Free article.

6

Immunosuppressive therapy abrogates unresponsiveness to renal allograft induced by thymic recognition of donor antigens.

Perico N, Imberti O, Bontempelli M, Remuzzi G. Perico N, et al. Among authors: bontempelli m. J Am Soc Nephrol. 1995 Feb;5(8):1618-23. doi: 10.1681/ASN.V581618. J Am Soc Nephrol. 1995. PMID: 7756595

7

Rituximab for idiopathic membranous nephropathy.

Remuzzi G, Chiurchiu C, Abbate M, Brusegan V, Bontempelli M, Ruggenenti P. Remuzzi G, et al. Among authors: bontempelli m. Lancet. 2002 Sep 21;360(9337):923-4. doi: 10.1016/S0140-6736(02)11042-7. Lancet. 2002. PMID: 12354476 Clinical Trial.

8

Intrathymic transplantation of donor cells allows a stabilized, incompatible renal transplant to survive indefinitely after cyclosporine withdrawal.

Perico N, Rossini M, Imberti O, Bontempelli M, Remuzzi G. Perico N, et al. Among authors: bontempelli m. Exp Nephrol. 1993 May-Jun;1(3):185-9. Exp Nephrol. 1993. PMID: 8081968

9

Colchicine allows prolonged survival of highly reactive renal allograft in the rat.

Ostermann D, Perico N, Imberti O, Barbui C, Bontempelli M, Remuzzi G. Ostermann D, et al. Among authors: bontempelli m. J Am Soc Nephrol. 1993 Dec;4(6):1294-9. doi: 10.1681/ASN.V461294. J Am Soc Nephrol. 1993. PMID: 8130355

10

The kidney triggers graft-versus-host disease in experimental combined transplantation of kidney and stem cell-enriched peripheral leukocytes.

Perico N, Amuchastegui S, Bontempelli M, Remuzzi G. Perico N, et al. Among authors: bontempelli m. J Am Soc Nephrol. 1996 Oct;7(10):2254-8. doi: 10.1681/ASN.V7102254. J Am Soc Nephrol. 1996. PMID: 8915987

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters